Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kamalakannan Velmurugan"'
Autor:
Bernd Eisele, Martin Gengenbacher, Reginald Kidd, David McCown, Sheldon Morris, Steven Derrick, David Hokey, Dominick Laddy, Rosemary Chang, Megan Fitzpatrick, Leander Grode, Kamalakannan Velmurugan, Stefan H.E. Kaufmann, John Fulkerson, Michael J. Brennan
Publikováno v:
Vaccines, Vol 1, Iss 2, Pp 120-138 (2013)
The failure of current Mycobacterium bovis bacille Calmette–Guérin (BCG) vaccines, given to neonates to protect against adult tuberculosis and the risk of using these live vaccines in HIV-infected infants, has emphasized the need for generating ne
Externí odkaz:
https://doaj.org/article/0faed53a9b714acc8f5dbb8a8015cef0
Publikováno v:
PLoS Pathogens, Vol 6, Iss 4, p e1000864 (2010)
The capacity of infected cells to undergo apoptosis upon insult with a pathogen is an ancient innate immune defense mechanism. Consequently, the ability of persisting, intracellular pathogens such as the human pathogen Mycobacterium tuberculosis (Mtb
Externí odkaz:
https://doaj.org/article/1d10ee2f90cb45be994f04b5d5669b34
Autor:
Kamalakannan Velmurugan, Bing Chen, Jessica L Miller, Sharon Azogue, Serdar Gurses, Tsungda Hsu, Michael Glickman, William R Jacobs, Steven A Porcelli, Volker Briken
Publikováno v:
PLoS Pathogens, Vol 3, Iss 7, p e110 (2007)
The survival and persistence of Mycobacterium tuberculosis depends on its capacity to manipulate multiple host defense pathways, including the ability to actively inhibit the death by apoptosis of infected host cells. The genetic basis for this anti-
Externí odkaz:
https://doaj.org/article/062a5058ca3f4baf8ceaa408291a7f21
Autor:
Johanna Poecheim, Yan Guo, Ming Guo, Kenneth Barry Walker, Lewis K. Schrager, Kamalakannan Velmurugan
Publikováno v:
Tuberculosis. 99:S12-S15
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6481d92a2d67f33b8b94394e6401f9ff
Publikováno v:
Tuberculosis. 99:S3-S7
Summary The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af1dfbcf94eee63e2a4b0752876ec58e
Autor:
Kamalakannan Velmurugan, Dominick Laddy, Megan Fitzpatrick, Steven C. Derrick, Reginald Kidd, Rosemary Chang, Martin Gengenbacher, David A. Hokey, John Fulkerson, David McCown, Michael J. Brennan, Leander Grode, Stefan H. E. Kaufmann, Sheldon L. Morris, Bernd Eisele
Publikováno v:
Vaccines; Volume 1; Issue 2; Pages: 120-138
Vaccines, Vol 1, Iss 2, Pp 120-138 (2013)
Vaccines
Vaccines, Vol 1, Iss 2, Pp 120-138 (2013)
Vaccines
The failure of current Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccines, given to neonates to protect against adult tuberculosis and the risk of using these live vaccines in HIV-infected infants, has emphasized the need for generating new,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e2e4e0ea0e7717847857f66dd3a889
Publikováno v:
BMC Microbiology, Vol 10, Iss 1, p 237 (2010)
BMC Microbiology
BMC Microbiology
Background The HIV pandemic raised the potential for facultative-pathogenic mycobacterial species like, Mycobacterium kansasii, to cause disseminating disease in humans with immune deficiencies. In contrast, non-pathogenic mycobacterial species, like
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6484f43b798d3158946f536ff584014
https://doi.org/10.1186/1471-2180-10-237
https://doi.org/10.1186/1471-2180-10-237
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 6, Iss 4, p e1000864 (2010)
PLoS Pathogens, Vol 6, Iss 4, p e1000864 (2010)
The capacity of infected cells to undergo apoptosis upon insult with a pathogen is an ancient innate immune defense mechanism. Consequently, the ability of persisting, intracellular pathogens such as the human pathogen Mycobacterium tuberculosis (Mtb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4efd9faddf1a77ef046bef2cc9c4bd5
https://pubmed.ncbi.nlm.nih.gov/20421951
https://pubmed.ncbi.nlm.nih.gov/20421951
Autor:
Bing Chen, Volker Briken, Michael S. Glickman, Sharon Azogue, Tsungda Hsu, Kamalakannan Velmurugan, Steven A. Porcelli, Serdar Abidin Gurses, Jessica L. Miller, William R. Jacobs
Publikováno v:
PLoS Pathogens, Vol 3, Iss 7, p e110 (2007)
PLoS Pathogens
PLoS Pathogens
The survival and persistence of Mycobacterium tuberculosis depends on its capacity to manipulate multiple host defense pathways, including the ability to actively inhibit the death by apoptosis of infected host cells. The genetic basis for this anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e6afab72579a23cc63375aad668d801
https://doi.org/10.1371/journal.ppat.0030110
https://doi.org/10.1371/journal.ppat.0030110